STE - Steris
207.49
| Index: | S&P 500 | P/E: | 47.39 | EPS (ttm): | 4.38 | Insider Own: | 0.31% | Shs Outstand: | 98.71M | Perf Week: | -3.14% |
| Market Cap: | 20.80B | Forward P/E: | 20.60 | EPS next Y: | 10.07 | Insider Trans: | -13.58% | Shs Float: | 98.40M | Perf Month: | -2.24% |
| Income(ttm): | 434.80M | PEG: | 4.74 | EPS next Q: | 2.32 | Inst Own: | 96.13% | Short Float: | 0.95% | Perf Quarter: | -13.32% |
| Revenue(ttm): | 5.42B | P/S: | 3.83 | EPS this Y: | 11.46% | Inst Trans: | -1.61% | Short Ratio: | 1.61 | Perf Half Y: | -4.19% |
| Book/sh: | 66.80 | P/B: | 3.11 | EPS next Y: | 10.19% | ROA: | 5.42% | Short Interest: | 0.94M | Perf Year: | -3.47% |
| Cash/sh: | 1.72 | P/C: | 120.78 | EPS next 5Y: | 10.00% | ROE: | 9.14% | 52W Range: | 197.82 - 248.24 | Perf YTD: | -5.62% |
| Dividend Est.: | 2.25 (1.09%) | P/FCF: | 30.58 | EPS past 5Y: | 1.36% | ROI: | 4.89% | 52W High: | -16.42% | Beta: | 0.84 |
| Dividend TTM: | 2.18 (1.05%) | Quick Ratio: | 1.55 | Sales past 5Y: | 14.25% | Gross Margin: | 43.14% | 52W Low: | 4.89% | ATR (14): | 4.65 |
| Dividend Ex-Date: | Nov 19, 2024 | Current Ratio: | 2.41 | EPS Y/Y TTM: | -20.70% | Oper. Margin: | 17.23% | RSI (14): | 38.01 | Volatility: | 2.14% 2.09% |
| Employees: | 18179 | Debt/Eq: | 0.36 | Sales Y/Y TTM: | 3.74% | Profit Margin: | 8.02% | Recom: | 1.89 | Target Price: | 255.50 |
| Option/Short: | Yes / Yes | LT Debt/Eq: | 0.35 | EPS Q/Q: | 30.37% | Payout: | 53.33% | Rel Volume: | 2.15 | Prev Close: | 204.34 |
| Sales Surprise: | -0.12% | EPS Surprise: | 0.81% | Sales Q/Q: | -1.00% | Earnings: | Nov 06 AMC | Avg Volume: | 583.01K | Price: | 207.49 |
| SMA20: | -3.01% | SMA50: | -5.30% | SMA200: | -7.55% | Undervalued: 23.14% | Volume: | 1,251,274 | Change: | 1.54% | |
Graham Classic formula value: 112.09
(P/E=8 * 1g) Min value: 70.8
(current P/E * 2g) Max value: 265.05
Average value: 149.31
STERIS Plc engages in the provision of healthcare and life science products and service solutions. It operates through the following segments: Healthcare, Life Sciences, Applied Sterilization Technologies, and Dental. The Healthcare segment provides a comprehensive offering for healthcare providers worldwide, focused on sterile processing departments and procedural centers, such as operating rooms and endoscopy suites. The Life Sciences segment designs, manufactures, and sells consumable products, equipment maintenance, specialty services, and capital equipment. The Applied Sterilization Technologies segment is involved in contract sterilization and testing services for medical device and pharmaceutical manufacturers. The Dental segment offers a comprehensive offering for dental practitioners and dental schools, offering instruments, infection prevention consumables and instrument management systems. The company was founded in 1985 and is headquartered in Dublin, Ireland.
Attention! Trading on the stock market involves financial risks and is not suitable for everyone. The www.stocks-expert.com does not provide financial market trading services; it is for informational purposes only and is not responsible for the consequences of your trading decisions or the operation of the software. Before starting to trade in any markets, make sure you understand the risks associated with trading and that you have a sufficient level of training.